The Effect of Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
The Effect of Inhalation Anesthesia and Total Intravenous Anesthesia on Systemic Inflammatory Immune Index in Major Abdominal Cancer Surgeries
1 other identifier
observational
84
1 country
1
Brief Summary
The effects of different anesthesia methods on the immune system are variable. In this study, we investigated the effect of inhalation anesthesia and total intravenous anesthesia on the SII value in major abdominal cancer surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2020
CompletedFirst Submitted
Initial submission to the registry
March 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 18, 2021
CompletedMay 18, 2021
March 1, 2021
6 months
March 17, 2021
May 14, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
investigate the effect of anesthesia management on the change of preoperative systemic inflammatory immune index(SII) and postoperative 2.hour and 24.hour SII value
systemic inflammatory immune index calculated by (platelet x neutrophil)/lymphocyte
preoperative SII noted, postoperative 2.hour noted and postoperative 24.hour noted
Study Arms (2)
Inhalation anesthesia
Sevoflurane for opioid remifentanyl used
Total Intravenous Anesthesia
Propofol for opioid remifentanyl used
Interventions
Systemic Inflammatory Immune index calculated from platelet, neutrophil and lymphocyte count
Eligibility Criteria
major abdominal cancer patients between 18-85 years included. 40 patients in sevoflurane group and 44 patients in TIVA group collected
You may qualify if:
- major abdominal cancer surgeries
You may not qualify if:
- blood transfusion in last 72 hours
- patients with infection
- hematologic malignancy
- patient controlled analgesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdurrahman Yurtaslan Oncology Research and Trainee Hospital
Ankara, Yenimahalle, 06200, Turkey (Türkiye)
Related Publications (2)
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014 Dec 1;20(23):6212-22. doi: 10.1158/1078-0432.CCR-14-0442. Epub 2014 Sep 30.
PMID: 25271081RESULTLee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016 Apr;69(2):126-32. doi: 10.4097/kjae.2016.69.2.126. Epub 2016 Mar 30.
PMID: 27066202RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arsen Gungor
arsen.gungor@hotmail.com
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist
Study Record Dates
First Submitted
March 17, 2021
First Posted
May 18, 2021
Study Start
March 5, 2020
Primary Completion
September 15, 2020
Study Completion
December 12, 2020
Last Updated
May 18, 2021
Record last verified: 2021-03